Golshan M - Search Results

1

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

Golshan M, Cirrincione CT, Sikov WM, Carey LA, Berry DA, Overmoyer B, Henry NL, Somlo G, Port E, Burstein HJ, Hudis C, Winer E, Ollila DW; Alliance for Clinical Trials in Oncology. Golshan M, et al. Breast Cancer Res Treat. 2016 Nov;160(2):297-304. doi: 10.1007/s10549-016-4006-6. Epub 2016 Oct 4. Breast Cancer Res Treat. 2016. PMID: 27704226 Free PMC article.

2

Metaplastic carcinoma of the breast with neuroglial differentiation.

Golshan M, Kuten A, William J, Richardson A, Modarressi A, Matulonis U. Golshan M, et al. Breast. 2006 Aug;15(4):545-9. doi: 10.1016/j.breast.2005.09.003. Epub 2005 Oct 25. Breast. 2006. PMID: 16253505

3

The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.

Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS. Golshan M, et al. Am J Surg. 2006 Jul;192(1):58-62. doi: 10.1016/j.amjsurg.2005.12.005. Am J Surg. 2006. PMID: 16769276

4

Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?

Golshan M, Nakhlis F. Golshan M, et al. Breast J. 2006 Sep-Oct;12(5):428-30. doi: 10.1111/j.1075-122X.2006.00299.x. Breast J. 2006. PMID: 16958960

5

Sentinel lymph node biopsy in men with breast cancer: a report of 31 consecutive procedures and review of the literature.

Rusby JE, Smith BL, Dominguez FJ, Golshan M. Rusby JE, et al. Among authors: golshan m. Clin Breast Cancer. 2006 Dec;7(5):406-10. doi: 10.3816/CBC.2006.n.058. Clin Breast Cancer. 2006. PMID: 17239266 Review.

6

Breast conservation for male breast carcinoma.

Golshan M, Rusby J, Dominguez F, Smith BL. Golshan M, et al. Breast. 2007 Dec;16(6):653-6. doi: 10.1016/j.breast.2007.05.012. Epub 2007 Jul 2. Breast. 2007. PMID: 17606375 Free article.

7

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M. Segara D, et al. Among authors: golshan m. J Surg Oncol. 2007 Nov 1;96(6):474-80. doi: 10.1002/jso.20856. J Surg Oncol. 2007. PMID: 17640031 Clinical Trial.

8

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E. Partridge A, et al. Among authors: golshan m. J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270338

9

Is axillary dissection needed in node-positive breast cancer?

Greenberg CC, Bafford AC, Golshan M. Greenberg CC, et al. Among authors: golshan m. Expert Rev Anticancer Ther. 2008 Feb;8(2):195-8. doi: 10.1586/14737140.8.2.195. Expert Rev Anticancer Ther. 2008. PMID: 18279060

10

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.

Bafford AC, Burstein HJ, Barkley CR, Smith BL, Lipsitz S, Iglehart JD, Winer EP, Golshan M. Bafford AC, et al. Among authors: golshan m. Breast Cancer Res Treat. 2009 May;115(1):7-12. doi: 10.1007/s10549-008-0101-7. Epub 2008 Jun 26. Breast Cancer Res Treat. 2009. PMID: 18581232 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page